RSV candidate ready for phase I in success for Boston Children's Hospital and Danish researchers
![Photo: Marijan Murat/AP/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14277377.ece/ALTERNATES/schema-16_9/21333157047351-4436x2496ma.jpg)
A RSV vaccine candidate for newborns, which was developed in a collaboration between Boston Children’s Hospital and researchers from the Danish State Serum Institute, SSI, has reported promising results after testing with mice, the Danish vaccine authority writes in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.